Carbidopa levodopa ent 100ml
Products billed under this code include Duopa.
Payment limit per 100 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Duopa.
Payment limit per 100 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Duopa | AbbVie Inc. | 00074-3012-07 | 7 | $1,701.756 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $243.108 | −$1.389 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted September 17, 2026 |
| 3Q26 | $244.497 | +$0.456 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted September 15, 2026 |
| 2Q26 | $244.041 | +$0.255 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted September 15, 2026 |
| 1Q26 | $243.786 | +$0.179 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted September 15, 2026 |
| 4Q25 | $243.607 | +$0.459 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted September 8, 2026 |
| 3Q25 | $243.148 | +$7.376 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted March 10, 2026 |
| 2Q25 | $235.772 | −$0.176 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted March 10, 2026 |
| 1Q25 | $235.948 | +$0.888 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted December 19, 2025 |
| 4Q24 | $235.06 | +$0.158 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 11, 2025 |
| 3Q24 | $234.902 | +$6.892 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 11, 2025 |
| 2Q24 | $228.01 | +$0.253 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted March 11, 2025 |
| 1Q24 | $227.757 | +$0.957 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted December 19, 2024 |
| 4Q23 | $226.80 | −$0.031 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted October 10, 2024 |
| 3Q23 | $226.831 | +$7.07 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 5, 2024 |
| 2Q23 | $219.761 | +$0.375 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted February 23, 2024 |
| 1Q23 | $219.386 | +$2.914 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted December 6, 2023 |
| 4Q22 | $216.472 | +$4.971 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 22, 2023 |
| 3Q22 | $211.501 | +$0.102 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 9, 2023 |
| 2Q22 | $211.399 | +$0.136 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted December 14, 2022 |
| 1Q22 | $211.263 | −$0.434 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 8, 2022 |
| 4Q21 | $211.697 | +$0.09 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 2, 2022 |
| 3Q21 | $211.607 | −$0.515 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted June 2, 2022 |
| 2Q21 | $212.122 | −$1.641 | 100 ML | Carbidopa levodopa ent 100ml | v1, posted March 1, 2022 |
| 1Q21 | $213.763 | – | 100 ML | Carbidopa levodopa ent 100ml | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.